Showing promise in the field of weight management treatment, retatrutide is a distinct strategy. Different from many available medications, retatrutide functions as a dual agonist, simultaneously targeting both GLP peptide-1 (GLP-1) and glucose-sensitive insulinotropic hormone (GIP) binding sites. This simultaneous stimulation promotes multiple adv